First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid

Y.T. Cho

Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, 10002 Taiwan

C.Y. Chu

Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, 10002 Taiwan

Corresponding Author

L.F. Wang

Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, 10002 Taiwan

Correspondence: Li-Fang Wang.

E-mail: [email protected]